News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
14 Results
Type
Article (3)
Press Release (10)
Section
Business (4)
Deals (2)
Drug Development (1)
News (5)
Tag
Academia (1)
Antibody-drug conjugate (ADC) (2)
Autoimmune disease (3)
Biologics (1)
Cancer (1)
CAR-T (1)
Cell therapy (2)
Clinical research (2)
Collaboration (3)
C-suite (2)
Data (1)
Executive appointments (1)
Funding (1)
Healthcare (1)
Immunology and inflammation (1)
Mergers & acquisitions (2)
Neuroscience (1)
Parkinson's disease (1)
Patient recruitment (1)
People (6)
Phase 1 (2)
Pipeline (1)
Series B (1)
Date
Last 365 days (11)
2026 (10)
2025 (2)
2024 (1)
2022 (1)
Location
California (2)
Canada (1)
Europe (1)
Florida (1)
Massachusetts (5)
New Jersey (1)
Northern California (2)
United States (9)
Washington State (4)
14 Results for "indupro".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
InduPro Announces Publication in Nature Establishing Spatial Protein Proximity as a New Framework for Therapeutic Discovery
September 9, 2026
·
6 min read
Press Releases
InduPro Closes $77 Million Series B Financing and Doses First Patient in Phase 1 Study of Lead Oncology Program IDP-001
August 12, 2026
·
5 min read
Press Releases
InduPro Therapeutics Appoints Amanda J. Redig, MD, PhD, as Chief Medical Officer
May 27, 2026
·
3 min read
Press Releases
InduPro Therapeutics Announces Strategic Collaboration with Lilly to Develop First-in-Class Bispecific/Multispecific Oncology Therapeutics Using InduPro’s Proximity-Guided Platform
January 8, 2026
·
3 min read
Collaboration
Lilly Bulks Up Inflammatory Pipeline With $1.2B Ventyx Buy, InduPro Cancer Pact
The deals will help Lilly diversify its portfolio that is heavily weighted on the obesity juggernaut tirzepatide, marketed as Mounjaro for diabetes and Zepbound for weight loss.
January 8, 2026
·
2 min read
·
Tristan Manalac
Press Releases
InduPro Therapeutics Announces Strategic Investment from Sanofi and a Research Collaboration to Advance a Novel Bispecific for Autoimmune Disorders
December 11, 2025
·
2 min read
Business
InduPro Announces $85 Million Series A Financing, Appoints Prakash Raman, Ph.D. as CEO to Advance Next-Generation, Proximity-Based Protein Therapeutics for the Treatment of Cancer and Autoimmune Diseases
InduPro, Inc. announced an $85 million Series A financing co-led by The Column Group and Vida Ventures with participation from investors, including MRL Ventures Fund, Emerson Collective and Euclidean Capital.
June 13, 2024
·
6 min read
Events
START’s Early Development Leaders Biotech Roundtable - Boston
You’re invited to a roundtable discussion on October 29 from 7:30-9am at the Ritz-Carlton Boston on early-phase oncology research.
October 1, 2026
Press Releases
Modulari-T Biosciences Names Tanya E. Borsuk, PhD, as Chief Executive Officer
April 21, 2026
·
3 min read
Mergers & acquisitions
Eli Lilly Enters CAR T Realm With $2.4B Orna Buy, Starting With Autoimmune
The deal gets Lilly access to Orna’s in vivo CAR T technology. The biotech’s lead asset, which has yet to start clinical testing, is focused on B cell–driven autoimmune diseases.
February 9, 2026
·
2 min read
·
Dan Samorodnitsky
1 of 2
Next